Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study

BACKGROUND: Reducing the risk of recurrent Plasmodium vivax malaria is critical for malaria control and elimination. Primaquine (PQ) is the only widely available drug against P. vivax dormant liver stages, but is recommended as a 14-day regimen, which can undermine adherence to a complete course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmalia, Annisa, Poespoprodjo, Jeanne Rini, Landuwulang, Chandra U. R., Ronse, Maya, Kenangalem, Enny, Burdam, Faustina H., Thriemer, Kamala, Devine, Angela, Price, Ric N., Peeters Grietens, Koen, Ley, Benedikt, Gryseels, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199529/
https://www.ncbi.nlm.nih.gov/pubmed/37210520
http://dx.doi.org/10.1186/s12936-023-04578-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199529/
https://www.ncbi.nlm.nih.gov/pubmed/37210520
http://dx.doi.org/10.1186/s12936-023-04578-3

Ejemplares similares